A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery

Pancrelipase Delayed-Release Capsules (CREON) for Exocrine Pancreatic Insufficiency due to Chronic Pancreatitis or Pancreatic Surgery: A Double-Blind Randomized Trial

(2010) David C Whitcomb et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis

(2010) Gavin R. Graff et al.   CLINICAL DRUG INVESTIGATION

Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study

(2010) Gavin R. Graff et al.   CLINICAL THERAPEUTICS

Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis

(2009) Bruce C. Trapnell et al.   Journal of Cystic Fibrosis

Efficacy and Tolerability of Creon for Children in Infants and Toddlers With Pancreatic Exocrine Insufficiency Caused by Cystic Fibrosis

(2009) Carla Colombo et al.   PANCREAS

Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis

(2008) A. K. WALJEE et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pancreatic enzyme replacement therapy for young cystic fibrosis patients

(2008) Anne Munck et al.   Journal of Cystic Fibrosis